Biostar Pharmaceuticals, Inc.
BSPM
Rank in Stocks
#35155
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets... Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$250.30
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Biostar Pharmaceuticals, Inc. (BSPM)
Category
Healthcare
EPS for Biostar Pharmaceuticals, Inc. (BSPM)
EPS as of September 2017 TTM: $0.68
According to Biostar Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $0.68. At the end of 2016 the company had an EPS of $-2.50, an increase over its 2015 EPS of $-11.36.
EPS history for Biostar Pharmaceuticals, Inc. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.68 | -127.20% |
| 2016 | $-2.50 | -77.99% |
| 2015 | $-11.36 | -593.91% |
| 2014 | $2.30 | 369.39% |
| 2013 | $0.49 | -103.35% |
| 2012 | $-14.63 | -259.54% |
| 2011 | $9.17 | -33.84% |
| 2010 | $13.86 | 94.12% |
| 2009 | $7.14 | 47.83% |
| 2008 | $4.83 | 15.00% |
| 2007 | $4.20 | 122.22% |
| 2006 | $1.89 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 856.09% |
DE
|
|
| $6.08 | 793.76% |
DE
|
|
| $1.55 | 128.03% |
JP
|
|
| $3.66 | 438.24% |
CH
|
|
| $0.45 | -33.82% |
IL
|
Questions about Biostar Pharmaceuticals, Inc.'s earnings per share (EPS)
What is Biostar Pharmaceuticals, Inc.'s earnings per share (EPS)?
Biostar Pharmaceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $0.68, as of Sep 2017.
What was Biostar Pharmaceuticals, Inc.'s earnings per share (EPS) in 2016?
In 2016, Biostar Pharmaceuticals, Inc.'s earnings per share (EPS) was $-2.50, compared with $-11.36 in 2015.
How has Biostar Pharmaceuticals, Inc.'s earnings per share (EPS) changed since 2011?
From 2011 to 2016, Biostar Pharmaceuticals, Inc.'s earnings per share (EPS) was highest in 2011 ($9.17) and lowest in 2012 ($-14.63).
How does Biostar Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Biostar Pharmaceuticals, Inc.'s earnings per share (EPS) ($0.68) is higher than that of 1 of the 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.